Aktis Oncology, Inc. (AKTS)

$19.48 +5.07%

EARNINGS ANALYTICS

Aktis Oncology, Inc. (AKTS) has only 1 recorded earnings event on file, so its post-earnings track record is limited. Its biggest recorded post-earnings gain was +8.16% (Mar 30, 2026) and its biggest decline was +8.16% (Mar 30, 2026).

Earnings Price Reaction

Scroll to zoom, drag to pan — click earnings dots for details

Beat Miss

Earnings Impact

Total Earnings

Avg Abs. Movement

±8.16%

Positive %

100.0%

Negative %

0.0%

Historical Earnings Statistics

Date	Timing	Open	High	Close	Volume	Movement %	SEC Filing
Mar 30, 2026	☽ POST	$14.94	$16.77	$16.54	452,300	+8.16%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±8.16%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

SEC Filing Types

description SCHEDULE 13D

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
SCHEDULE 13G	20260514	open_in_new SEC.gov
4	20260416	open_in_new SEC.gov
3	20260416	open_in_new SEC.gov
8-K	20260416	open_in_new SEC.gov
8-K	20260330	open_in_new SEC.gov
10-K	20260330	open_in_new SEC.gov
SCHEDULE 13D	20260120	open_in_new SEC.gov
SCHEDULE 13D	20260120	open_in_new SEC.gov
SCHEDULE 13D	20260115	open_in_new SEC.gov
3	20260115	open_in_new SEC.gov

Frequently asked about AKTS earnings

How much does AKTS stock move after earnings? expand_more

Over 1 reports, AKTS has moved an average of ±8.16% the session after earnings, closing higher 100.0% of the time.

What was AKTS's biggest post-earnings move? expand_more

AKTS's largest post-earnings gain on record was +8.16% on Mar 30, 2026, and its largest decline was +8.16% on Mar 30, 2026.

Where can I find Aktis Oncology, Inc.'s SEC filings? expand_more

All of Aktis Oncology, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.